Lineage Cell Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2009 | — | -182.9% | -267.2% |
| FY2010 | 99.3% | -265.7% | -301.6% |
| FY2011 | 98.2% | -421.4% | -372.5% |
| FY2012 | 88.9% | -638.5% | -547.2% |
| FY2013 | 82.1% | -1,262.7% | -989.7% |
| FY2014 | 84.0% | -966.5% | -694.4% |
| FY2015 | 84.3% | -935.3% | -667.9% |
| FY2016 | 94.0% | -995.6% | 566.8% |
| FY2017 | 95.1% | -1,125.0% | -577.7% |
| FY2018 | 93.9% | -837.9% | -922.0% |